Congenital mitral valve cleft leaflet
ICD-10 Q23.82 is a billable code used to indicate a diagnosis of congenital mitral valve cleft leaflet.
Congenital mitral valve cleft leaflet is a specific type of congenital heart defect characterized by a cleft or split in one of the leaflets of the mitral valve. This malformation can lead to significant hemodynamic consequences, including mitral regurgitation, which may result in volume overload of the left atrium and ventricle. The condition is often associated with other congenital heart defects, such as atrial septal defects or ventricular septal defects, and may be part of syndromic presentations. Diagnosis typically involves echocardiography, which can visualize the cleft and assess its impact on cardiac function. Management may require surgical intervention, particularly if the defect leads to symptomatic heart failure or significant regurgitation. Early detection and appropriate management are crucial to improving outcomes in affected pediatric patients.
Pediatric documentation should include growth parameters, developmental milestones, and specific symptoms related to heart function.
Common scenarios include routine pediatric check-ups where a heart murmur is detected, leading to further investigation and diagnosis of the cleft mitral valve.
Consideration should be given to the patient's age, growth, and any associated syndromic features that may impact management.
Genetic documentation should include family history of congenital heart defects and any syndromic associations.
Genetic counseling may be sought for families with a history of congenital heart disease, particularly if there are multiple affected family members.
Genetic testing may be indicated to rule out chromosomal abnormalities associated with congenital heart defects.
Used in cases where surgical intervention is required for cleft mitral valve.
Operative report detailing the procedure and findings.
Pediatric cardiology should document the rationale for surgery and expected outcomes.
Accurate coding of Q23.82 is crucial for ensuring appropriate management and treatment of patients with congenital mitral valve cleft leaflet. It impacts clinical decision-making, reimbursement, and the overall understanding of congenital heart defects in pediatric populations.
